In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diagnostic Products Corp.: Thriving, For Now

Executive Summary

The popularity of DPC's random-access immunoassay system, the Immulite 2000, has helped the company become a significant player in the highly competitive automated immunoassay market. But DPC's benefited from some good luck--namely the misfortunes of top player Abbott Diagnostics and the slow efforts by other competitors to step into the gap left by Abbott. DPC's dilemma is whether it can maintain its narrow focus as Abbott re-emerges and other competitors get stronger.
Advertisement

Related Content

bioMerieux, a Family-Owned French Firm, Finally Goes Public
An Independent Pharmacia Diagnostics Charts an Independent Course
Sysmex Bets on Best of Breed
Post Abbott Consent Decree; A Changed World for Immunoassay Vendors
Post Abbott Consent Decree; A Changed World for Immunoassay Vendors
D-Day for Abbott
D-Day for Abbott
Abbott Gets Into Hot Water
Abbott Gets Into Hot Water
Diagnostic Products Corp.'s Contrarian Bet

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002101

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel